Larvol Delta - CoImmune-Inc-Announces-FDA-Approval-of-its-IND-Application-to-Conduct-a-Phase-2b-Clinical-Trial-with-CMN001-in-Advanced-RCC-Patients

CMN-001 - CoImmune

http://www.globenewswire.com/news-release/2020/02/19/1986965/0/en/CoImmune-Inc-Announces-FDA-Approval-of-its-IND-Application-to-Conduct-a-Phase-2b-Clinical-Trial-with-CMN-001-in-Advanced-RCC-Patients.html

Feb 19, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next